JOHNSON ALAN G 4
4 · KV PHARMACEUTICAL CO /DE/ · Filed Oct 21, 2003
Insider Transaction Report
Form 4
KV PHARMACEUTICAL CO /DE/KVA, KVB
JOHNSON ALAN G
DirectorSr. V.P. & Sec.
Transactions
- Exercise/Conversion
Class B Common
2003-10-17$7.04/sh+63,437$446,279→ 161,312 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2003-10-17$3.23/sh−3,375$10,891→ 6,750 totalExercise: $3.23From: 1996-11-06Exp: 2006-11-06→ Class A Common (3,375 underlying) - Exercise/Conversion
Class A Common
2003-10-17$3.23/sh+3,375$10,891→ 192,405 total - Tax Payment
Class A Common
2003-10-17$23.91/sh−68,289$1,632,790→ 124,116 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2003-10-17$6.79/sh−90,030$610,854→ 22,470 totalExercise: $6.79From: 1999-10-13Exp: 2004-10-13→ Class A Common (90,030 underlying) - Exercise/Conversion
Class A Common
2003-10-17$6.79/sh+90,030$610,854→ 189,030 total - Exercise/Conversion
Incentive Stock Option (Right to Buy)
2003-10-17$7.04/sh−63,437$446,279→ 49,063 totalExercise: $7.04From: 1999-10-13Exp: 2004-10-13→ Class B Common (63,437 underlying) - Tax Payment
Class B Common
2003-10-17$24.08/sh−15,625$376,250→ 145,687 total